home / stock / pfe / pfe articles

PFE Articles, Pfizer Inc. - From 11/28/23

Stock Information
Company Name: Pfizer Inc.
Stock Symbol: PFE
Market: NYSE
Website: pfizer.com
Menu
PFE PFE Quote PFE Short PFE News PFE Articles PFE Message Board
Get PFE Alerts

News, Short Squeeze, Breakout and More Instantly...
Arvinas and Pfizer Announce Updated Vepdegestrant (ARV-471) Data to be Presented at the 2023 San Antonio Breast Cancer Symposium | Benzinga

-- Six abstracts have been accepted for presentation, including updated data on vepdegestrant alone and in combination with palbociclib (IBRANCE&#...
Merck Highlights Data On New Vaccine, Compares 'Tolerability And Safety' To Pfizer's | Benzinga

Merck & Co Inc (NYSE: MRK) released results from the STRIDE-3 Phase 3 trial evaluating V116, the company's investigational 21-valent&n...

Why Is COVID-19 Vaccine Maker Moderna Stock Trading Lower Today? | Benzinga

Moderna Inc (NASDAQ: MRNA) shares slipped on Tuesday trading after the European Patent Office said a contested mRNA patent owned by Moderna is...

Can Weight-Loss Drug Ozempic Tip The Scales For Tema's New Healthcare ETF? | Benzinga

Tema, the exchange-traded fund platform, has launched a healthcare ETF focused on companies that research and treat cardiovascular disease and cond...
Analyst Assess Implications of Bristol Myers' Investigational Blood Thinner Post Bayer Trial Setback Amid Shaken Investor Confidence | Benzinga

Monday, Bayer AG (OTC: BAYRY) (OTC: BAYZF) stopped the OCEANIC-AF Phase 3 study early after asundexian showed inferiority to&nb...

Bayer's Blood Thinner Study Stopped Early Due To Lack Of Efficacy: Details | Benzinga

Bayer AG (OTC: BAYRY) (OTC: BAYZF) stopped the OCEANIC-AF Phase 3 study investigating asundexian compared to apixaban (a direct oral...

What's Going On With Penny Stock AgeX Therapeutics? | Benzinga

Serina Therapeutics Inc, a privately held, clinical-stage biotechnology company, entered into a License Agreement under which Pfizer Inc ...
Acuitas Challenges CureVac in Legal Tussle Over COVID-19 Vaccine Technology | Benzinga

Biotech company Acuitas Therapeutics has filed a lawsuit in Virginia federal court against Germany-based CureVac SE (NASDAQ: CV...

Pfizer's Cost-Cutting Measures: 500 Job Cuts in Kent Facility, Higher Than Anticipated | Benzinga

Pfizer Inc (NYSE: PFE) is reportedly discontinuing its pharmaceutical sciences small molecule (PSSM) operations at Sandwich in Kent to streaml...

What Are Pfizer's Prospects In Obesity Pill Market? Analysts Say Optimism, Cautiousness Surround With Data Awaited Next Year | Benzinga

Pfizer Inc (NYSE: PFE) is turning its focus to the weight loss drug market, aiming to capture a $10 billion segment with its experimental obes...
Previous 10 Next 10